Skip to content

A retrospective analysis of airway inflammation–related clinical phenotypes in wheezing children caused by respiratory syncytial virus (RSV) and Mycoplasma pneumoniae infection

A retrospective analysis of airway inflammation–related clinical phenotypes in wheezing children caused by respiratory syncytial virus (RSV) and Mycoplasma pneumoniae infection

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600124914
Enrollment
Unknown
Registered
2026-05-19
Start date
2024-08-21
Completion date
Unknown
Last updated
2026-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric wheezing associated with respiratory syncytial virus (RSV) and Mycoplasma pneumoniae (MP) infection

Interventions

RSV infection group:None
Mycoplasma infection group:None

Sponsors

Shanghai Children’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 14 Years

Inclusion criteria

Inclusion criteria: 1. Patients who meet the Western medical diagnostic criteria for SMPP and the traditional Chinese medicine syndrome differentiation criteria; 2. Children aged 5–14 years; 3. Children or their legal guardians who provide informed consent and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients found by etiological testing within 7 days after admission to have concomitant bacterial, viral, tuberculosis, or other pathogen infections; 2. Patients complicated with asthma or other immune diseases, or those receiving immunomodulatory agents; 3. Patients with severe complications such as heart failure, respiratory failure, or hypoxic encephalopathy; 4. Patients with severe hepatic or renal diseases, cardiovascular diseases, hematological diseases, or neurological diseases, or those with a recent history of severe pneumonia that has not fully resolved; 5. Patients allergic to azithromycin or the investigational traditional Chinese medicine; 6. Patients judged by the physician to be likely to be lost to follow-up; 7. Patients with incomplete medical records.

Design outcomes

Primary

MeasureTime frame
Healing rate and improvement rate;

Secondary

MeasureTime frame
Duration of wheezing;Duration of fever;Duration of cough;White blood cell count;C-reactive protein;Chest imaging;Discharge outcome;

Countries

China

Contacts

Public ContactXiaoping Jing

Shanghai Children’s Hospital

xiaopingjdoctor@126.com+86 159 2192 5559

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 30, 2026